Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
World Journal of Clinical Oncology|February 25, 2025
Correlation between gut microbiota and tumor immune microenvironment: A bibliometric and visualized studyZheng-Jun Hu, Hui-Rong Zhu, Yong-Jie Jin, et al.
Chinese Journal of Integrative Medicine|April 2, 2013
Effects of Jianpi Jiedu Recipe on reversion of P-glycoprotein-mediated multidrug resistance through COX-2 pathway in colorectal cancerHua Sui, Hui-rong Zhu, Jie Wu, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 16, 2013
Anti-tumor activity and apoptosis-regulation mechanisms of bufalin in various cancers: new hope for cancer patientsPei-Hao Yin, Xuan Liu, Yan-Yan Qiu, et al.
World Journal of Gastrointestinal Oncology|April 16, 2025
Trends in nanomedicine for colorectal cancer treatment: Bibliometric and visualization analysis (2010-2024)Yu-Ren Zhang, Hui-Rong Zhu, Hao-Ran Li, et al.
Zhong Xi Yi Jie He Xue Bao = Journal of Chinese Integrative Medicine|March 17, 2009
[Changes of tongue and pulse parameters in 50 lung cancer patients treated with integrated traditional Chinese and Western medicine]Hai-xia Yan, Yi-qin Wang, Hui-rong Zhu, et al.
Molecular Cancer Therapeutics|September 11, 2014
miR200c attenuates P-gp-mediated MDR and metastasis by targeting JNK2/c-Jun signaling pathway in colorectal cancerHua Sui, Guo-Xiang Cai, Shu-Fang Pan, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|March 28, 2013
Zuo Jin Wan, a Traditional Chinese Herbal Formula, Reverses P-gp-Mediated MDR In Vitro and In VivoHua Sui, Xuan Liu, Bao-Hui Jin, et al.
Journal of Cellular Biochemistry|November 22, 2015
Evodiamine Suppresses ABCG2 Mediated Drug Resistance by Inhibiting p50/p65 NF-κB Pathway in Colorectal CancerHua Sui, Li-Hong Zhou, Ya-Li Zhang, et al.
BMC Complementary and Alternative Medicine|August 3, 2014
Zuo Jin Wan reverses P-gp-mediated drug-resistance by inhibiting activation of the PI3K/Akt/NF-κB pathwayHua Sui, Shu-Fang Pan, Yu Feng, et al.
Frontiers in Pharmacology|July 2, 2025
Tricin selectively combats KRAS-mutant non-small cell lung cancer by inhibiting the PDGF-BB-induced SRC/MAPK/AP-1/PD-L1 signaling pathway and potentiating the antitumor effect of an anti-PD-1 antibodyJia-Xin Li, Shi-Yu Tan, Li-Qi Li, et al.
Pageof 1